March 28, 2017
Kadmon Presents Preclinical Data Supporting the Therapeutic Potential of ROCK Inhibition in Pulmonary Fibrosis
March 22, 2017
Kadmon Reports Upcoming Milestones and Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017
Kadmon Announces Approximately $23 Million Equity Financing
Learn more about investing in our growth.
Receive press releases, SEC filings and more.
Subscribe to alerts
Kadmon Corporation, LLC
Copyright 2017. All Rights Reserved.